Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in

Bo Chen1, Pengzhen Lin1, Nan Li2

  • 1Department of Neurosurgery, Shaanxi Provincial People's Hospital, No. 256 West Youyi Road, Xi'an, 710068, Shaanxi, China.

Abstract

Insights

The long non-coding RNA LINC00324 acts as an oncogene in glioblastoma (GBM), promoting tumor growth and progression. Targeting LINC00324 may offer new therapeutic strategies for GBM patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (LncRNAs) are recognized as key regulators and potential biomarkers in glioblastoma (GBM).
  • The specific role of the novel LncRNA LINC00324 in GBM progression remains largely uninvestigated.

Purpose of the Study:

  • To elucidate the function of LINC00324 in GBM development.
  • To uncover the molecular mechanisms underlying LINC00324's role in GBM.

Main Methods:

  • Retrospective analysis of GBM patient data and LINC00324 expression using Real-time qPCR.
  • In vitro and in vivo loss-of-function experiments to assess LINC00324's impact on GBM cell proliferation, migration, and apoptosis.
  • Bioinformatic analysis and dual luciferase reporter assays to identify and validate LINC00324's targeting genes.

Main Results:

  • LINC00324 is significantly upregulated in GBM tissues and cells, correlating with poorer patient prognosis.
  • Silencing LINC00324 inhibits GBM cell proliferation, migration, and tumorigenesis, while promoting apoptosis.
  • LINC00324 functions as a competing endogenous RNA, sponging miR-16-5p to upregulate SEPT2, thereby promoting GBM malignancy.

Conclusions:

  • LINC00324 promotes GBM malignant phenotypes by regulating the miR-16-5p/SEPT2 axis.
  • LINC00324 represents a potential novel biomarker for GBM diagnosis and a therapeutic target.

Related Concept Videos